InMode Ltd. (INMD)

Market Cap	903.26M
Revenue (ttm)	392.41M
Net Income (ttm)	175.78M
Shares Out	63.21M
EPS (ttm)	2.29
PE Ratio	6.25
Forward PE	8.37
Dividend	n/a
Ex-Dividend Date	n/a

Volume	402,255
Open	14.65
Previous Close	14.76
Day's Range	14.26 - 14.65
52-Week Range	13.68 - 19.85
Beta	2.02
Analysts	Hold
Price Target	17.56 (+22.88%)
Earnings Date	Apr 28, 2025

About INMD

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women’s health conditions and procedu...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Aug 8, 2019
• Employees: 599
• Stock Exchange: NASDAQ
• Ticker Symbol: INMD
• Website: https://www.inmodemd.com

Financial Performance

In 2024, InMode's revenue was $394.82 million, a decrease of -19.76% compared to the previous year's $492.05 million. Earnings were $181.28 million, a decrease of -8.41%.

Analyst Forecast

According to 6 analysts, the average rating for INMD stock is "Hold." The 12-month stock price forecast is $17.56, which is an increase of 22.88% from the latest price.

Price Target

$17.56

(22.88% upside)

Analyst Consensus: Hold